IPCA Laboratories Ltd Q1 FY2024 consolidated net profit at Rs. 162.82 crores

has reported Consolidated financial results for the period ended June 30, 2023.

Financial Results (Q1 FY2024) - QoQ Comparison

The company has reported total income of Rs. 1632.43 crores during the period ended June 30, 2023 as compared to Rs. 1548.02 crores during the period ended March 31, 2023.

The company has posted net profit / (loss) of Rs. 162.82 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs. 76.52 crores for the period ended March 31, 2023.

The company has reported EPS of Rs. 6.42 for the period ended June 30, 2023 as compared to Rs. 3.02 for the period ended March 31, 2023.

Financials	Q1 FY2024	Q4 FY2023	% Change
Total Income	₹ 1632.43 crs	₹1548.02 crs	5.45%
Net Profit	₹162.82 crs	₹76.52 crs	112.78%
EPS	₹6.42	₹3.02	112.58%

Financial Results (Q1 FY2024) - YoY Comparison

The company has reported total income of Rs. 1632.43 crores during the period ended June 30, 2023 as compared to Rs.1607.85 crores during the period ended June 30, 2022.

The company has posted net profit / (loss) of Rs.162.82 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs.143.06 crores for the period ended June 30, 2022.

The company has reported EPS of Rs.6.42 for the period ended June 30, 2023 as compared to Rs.5.64 for the period ended June 30, 2022.

Financials	Q1 FY2024	Q1 FY2023	% Change
Total Income	₹ 1632.43 crs	₹1607.85 crs	1.53%
Net Profit	₹162.82 crs	₹143.06 crs	13.81%
EPS	₹6.42	₹5.64	13.83%

Source : Equity Bulls

Keywords

IPCALaboratories Q1FY24 ResultUpdate